Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Provention Bio, Inc. - Common Stock (NQ:PRVB)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 26, 2023 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	-
Bid (Size)	24.97 (100)
Ask (Size)	25.05 (8)
Prev. Close	24.98
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	94,780,874
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Tiziana Life Sciences (NASDAQ: TLSA) Announces Positive Data In Its Secondary-Progressive Multiple Sclerosis Trial, What Could This Mean For The Company? ↗

June 15, 2023

Company Moves Ahead With Drug Development

Via Benzinga

Provention Bio Inc. (NASDAQ: PRVB) Highlighted for Surprising Price Action

April 26, 2023

Via Investor Brand Network

Performance

More News

Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis ↗

April 19, 2023

Via Benzinga

Treatments For Non-Active Secondary Progressive Multiple Sclerosis Remain Scarce – Tiziana Life Sciences' (NASDAQ: TLSA) First-In-Class Foralumab Is Showing Promise ↗

April 12, 2023

Via Benzinga

Is Sanofi Stock a Buy Now? ↗

March 25, 2023

Via The Motley Fool

Provention Bio's Earnings Outlook ↗

March 15, 2023

Via Benzinga

4 Analysts Have This to Say About Provention Bio ↗

March 14, 2023

Via Benzinga

Provention Bio, Inc. (NASDAQ: PRVB) Making Surprising Moves in Monday Session

March 13, 2023

Via Investor Brand Network

Sanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Information ↗

April 11, 2023

Via Benzinga

PROVENTION BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Provention Bio, Inc. - PRVB

March 29, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Oak Street Health (NYSE – OSH), Seagen Inc. (Nasdaq - SGEN), Provention Bio Inc. (Nasdaq - PRVB), Kimball International, Inc. (Nasdaq – KBAL)

March 23, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Top 5 Health Care Stocks That May Crash In March ↗

March 22, 2023

Via Benzinga

Stock Market Diverges Amid Bank Woes, Growth Gains; First Republic, Credit Suisse, Meta In Focus: Weekly Review ↗

March 17, 2023

Via Investor's Business Daily

Why Provention Bio Stock Skyrocketed 256% This Week ↗

March 16, 2023

Via The Motley Fool

Why Shares of MacroGenics Climbed Thursday ↗

March 16, 2023

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2023 ↗

March 15, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023 ↗

March 14, 2023

Via Benzinga

Top 5 Health Care Stocks That Are Ticking Portfolio Bombs ↗

March 14, 2023

Via Benzinga

PROVENTION BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Provention Bio, Inc. - PRVB

March 13, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners ↗

March 13, 2023

Via The Motley Fool

Nasdaq Up 150 Points; Gold Rises Over 2% ↗

March 13, 2023

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qualtrics (Nasdaq - XM), Seagen Inc. (Nasdaq - SGEN), Provention Bio Inc. (Nasdaq - PRVB), Kimball International, Inc. (Nasdaq – KBAL)

March 13, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Sanofi (NASDAQ: SNY) Set to Acquire Provention Bio (NASDAQ: PRVB) for $2.9 Billion

March 13, 2023

Via Spotlight Growth

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 13, 2023

Via Benzinga

Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 13, 2023

Via Benzinga

Frequently Asked Questions

Is Provention Bio, Inc. - Common Stock publicly traded?

Yes, Provention Bio, Inc. - Common Stock is publicly traded.

What exchange does Provention Bio, Inc. - Common Stock trade on?

Provention Bio, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Provention Bio, Inc. - Common Stock?

The ticker symbol for Provention Bio, Inc. - Common Stock is PRVB on the Nasdaq Stock Market

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.